Delivery Order SPE2DB20D3111-SPE2DB25FA6QD
Award Date
1/31/25
Potential Completion Date
2/24/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.30 firm fixed-price delivery order is for the procurement of KEDRAB 300 UNIT/2 ML VIAL 2ML medical supplies. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,320.48 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,500 units of the drug KEDRAB, a 10 ml vial, with an ultimate completion date of August 28, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,297.08 firm fixed-price delivery order is for the provision of the pharmaceutical product KEDRAB 300 UNIT/2 ML VIAL 2ML. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - a single-award IDC with DLA Troop Support Medical...
This federal contract award, valued at $3,242.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of KEDRAB, a 1,500 unit/10 mL vial medication, to the Defense Logistics Agency (DLA). The $12,569.76 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.20 firm-fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a specialty medication. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KEDRAB, a 1,500 unit/10 mL vial of the medication KEDRAB, with a ceiling value of $3,248.74. The award does not have a set-aside designation. The contract has a firm fixed price and is set to be completed by August 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.20 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,805.20 firm fixed-price delivery order is for the supply of 1,500 units of the drug KEDRAB (10 ML vial) with a period of performance through December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...